Company / Total Debt
Fortress Biotech, Inc. Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$52.4M
FY2025
5-year range
$42.9M / $91.7M
FY2021-FY2025
Trend
-9.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Debt has declined for 3 consecutive years, from $92M in FY2022 to $52M in FY2025.
Based on SEC 10-K filings.
$52M in FY2025 with a 5-year CAGR of -9.1%.
Improved from $61M to $52M over the past 2 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- -17.0%
- 5-Year CAGR
- -9.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Fortress Biotech, Inc.'s total debt has declined for 3 consecutive years.
- 5-year CAGR of -9.1%, indicating a declining trend.
- In FY2025, total debt decreased 9.6% year-over-year.
- Peak total debt was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $52.4M | -9.6% |
| FY2024 | $58.0M | -4.8% |
| FY2023 | $60.9M | -33.7% |
| FY2022 | $91.7M | +113.6% |
| FY2021 | $42.9M | -49.3% |
| FY2020 | $84.7M | -5.7% |
| FY2019 | $89.7M | +6.3% |
| FY2018 | $84.4M | +25.0% |
| FY2017 | $67.5M | +123.5% |
| FY2016 | $30.2M | +25.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026